Marie‐Hélène Horellou

Author

Also Known As

M H Horellou, MARIE-HELÈNE HORELLOU, Marie-Helene Horellou, Marie-Hèléne Horellou, Marie-Hélene Horellou, Marie-Hélenè Horellou, Marie-Hélène Horellou, Marie‐Hélène Horellou

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Hôtel-Dieu de Paris Université Paris Cité Inserm Délégation Paris 5 Assistance Publique – Hôpitaux de Paris

About

Marie‐Hélène Horellou is an author at Hôtel-Dieu de Paris specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	456
2	Public Health	3	3	245
3	Health Sciences	2	2	52
4	Biochemistry	1	1	12
5	Emergency Medicine	1	1	75

Marie‐Hélène Horellou

Publications

884

Citations

H-Index

Page 1

	Year	Citations
Progestogen-only contraception in women at high risk of venous thromboembolism Jacqueline Conard, Geneviève Plu‐Bureau, Narges Bahi, Contraception ContraceptionContraceptive UseHormonal ContraceptiveFertilitySexual And Reproductive Health	2004	138
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women Valérie Olié, Geneviève Plu‐Bureau, Jacqueline Conard, Menopause The Journal of The North American Menopause Society	2010	117
Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays Claire Flaujac, Xavier Delavenne, Sara Quenet, Thrombosis and Haemostasis	2013	112
A Noninvasive Diagnostic Strategy Including Spiral Computed Tomography in Patients with Suspected Pulmonary Embolism Christine Lorut, MICHEL GHOSSAINS, Marie‐Hélène Horellou, American Journal of Respiratory and Critical Care Medicine Emergency RadiologyPulmonary EmbolismThrombosisSpiral CtVenous Thrombosis	2000	75
Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency Martine Alhenc‐Gelas, Geneviève Plu‐Bureau, Justine Hugon‐Rodin, Thrombosis and Haemostasis	2017	68
Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations Anne Godiér, Anne‐Céline Martin, Isabelle Leblanc, Thrombosis Research ThrombosisDrug ConcentrationsTherapeutic Drug MonitoringMedicinePharmacotherapy	2015	49
Improving Anticoagulation Control in Hospitalized Elderly Patients on Warfarin Isabelle Gouin‐Thibault, Camille Lévy, Éric Pautas, Journal of the American Geriatrics Society	2010	41
Heparin-induced thrombocytopenia: laboratory diagnosis and management. Ismaı̈l Elalamy, C Lecrubier, Marie‐Hélène Horellou, PubMed ImmunohematologyImmunologyPathologyThrombosisTranslational Medicine	2000	41
Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism Justine Hugon‐Rodin, Marie‐Hélène Horellou, Jacqueline Conard, Thrombosis and Haemostasis	2018	41
Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone Meyer‐Michel Samama, Roberto Abi Rached, Marie‐Hélène Horellou, British Journal of Haematology Family MembersGeneticsCombined ThrombophiliaGenetic EpidemiologyReproductive Health	2003	32

Page 1